Cargando…

Loss of FBXW7-mediated degradation of BRAF elicits resistance to BET inhibitors in adult T cell leukemia cells

BACKGROUND: Human T cell leukemia virus type 1 (HTLV-1)-associated adult T cell leukemia (ATL) has a very poor prognosis with a median survival of 8 months and a 4-year overall survival of 11% for acute ATL. Present treatment options are limited and there is no curative therapy for ATL. Ubiquitin li...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yeh, Chien-Hung, Bellon, Marcia, Wang, Fang, Zhang, Hong, Fu, Liwu, Nicot, Christophe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7487643/ https://www.ncbi.nlm.nih.gov/pubmed/32907612 http://dx.doi.org/10.1186/s12943-020-01254-x

Ejemplares similares

FBXW7: a critical tumor suppressor of human cancers
por: Yeh, Chien-Hung, et al.
Publicado: (2018)

Clinical significance of FBXW7 loss of function in human cancers
por: Fan, Jingyi, et al.
Publicado: (2022)

FHIT as a biomarker for early screening of adult T-cell leukemia
por: Bellon, Marcia, et al.
Publicado: (2021)

Clinical significance of microRNAs in chronic and acute human leukemia
por: Yeh, Chien-Hung, et al.
Publicado: (2016)

STAT1: A Novel Target of miR-150 and miR-223 Is Involved in the Proliferation of HTLV-I–Transformed and ATL Cells()
por: Moles, Ramona, et al.
Publicado: (2015)

FBXW7 E3 ubiquitin ligase: degrading, not degrading, or being degraded
por: Lan, Huiyin, et al.
Publicado: (2019)

Telomere Dynamics in Immune Senescence and Exhaustion Triggered by Chronic Viral Infection
por: Bellon, Marcia, et al.
Publicado: (2017)

Targeting Pim kinases in hematological cancers: molecular and clinical review
por: Bellon, Marcia, et al.
Publicado: (2023)

BET and BRAF inhibitors act synergistically against BRAF‐mutant melanoma
por: Paoluzzi, Luca, et al.
Publicado: (2016)

Loss of CDC4/FBXW7 in Gastric Carinoma
por: Milne, A. N., et al.
Publicado: (2010)

FBXW7-mediated ERK3 degradation regulates the proliferation of lung cancer cells
por: An, Hyun-Jung, et al.
Publicado: (2022)

NOTCH1 Activation Depletes the Pool of Side Population Stem Cells in ATL
por: Bai, Xue Tao, et al.
Publicado: (2017)

JAG1 overexpression contributes to Notch1 signaling and the migration of HTLV-1-transformed ATL cells
por: Bellon, Marcia, et al.
Publicado: (2018)

Tumor Suppressor Inactivation in the Pathogenesis of Adult T-Cell Leukemia
por: Nicot, Christophe
Publicado: (2015)

Mutation of epigenetic regulators TET2 and MLL3 in patients with HTLV-I-induced acute adult T-cell leukemia
por: Yeh, Chien-Hung, et al.
Publicado: (2016)

CircFBXW7 in patients with T-cell ALL: depletion sustains MYC and NOTCH activation and leukemia cell viability
por: Buratin, Alessia, et al.
Publicado: (2023)

Erratum to: ‘Mutation of epigenetic regulators TET2 and MLL3 in patients with HTLV-I-induced acute adult T-cell leukemia’
por: Yeh, Chien-Hung, et al.
Publicado: (2016)

A widely used pan-isoform-FBXW7 antibody used in cell cycle studies does not detect FBXW7
por: Ennis, Hannah, et al.
Publicado: (2023)

FBXW8-dependent degradation of MRFAP1 in anaphase controls mitotic cell death
por: Li, Duan-Zhuo, et al.
Publicado: (2017)

CDK1/FBXW7 facilitates degradation and ubiquitination of MLST8 to inhibit progression of renal cell carcinoma
por: Zhang, Encheng, et al.
Publicado: (2021)

Regulation of BRAF protein stability by a negative feedback loop involving the MEK–ERK pathway but not the FBXW7 tumour suppressor
por: Hernandez, Maria Aguilar, et al.
Publicado: (2016)

Regulation of SOX10 stability via ubiquitination-mediated degradation by Fbxw7α modulates melanoma cell migration
por: Lv, Xiao-Bin, et al.
Publicado: (2015)

The Role of FBXW7 in Gynecologic Malignancies
por: Di Fiore, Riccardo, et al.
Publicado: (2023)

BRAF Mutation in Hairy Cell Leukemia
por: Ahmadzadeh, Ahmad, et al.
Publicado: (2014)

FBXW7 influences murine intestinal homeostasis and cancer, targeting Notch, Jun, and DEK for degradation
por: Babaei-Jadidi, Roya, et al.
Publicado: (2011)

Meta-analysis of the clinical characteristics and prognostic relevance of NOTCH1 and FBXW7 mutation in T-cell acute lymphoblastic leukemia
por: Liu, Rong-Bin, et al.
Publicado: (2017)

Role of Fbxw7 in the maintenance of normal stem cells and cancer-initiating cells
por: Takeishi, S, et al.
Publicado: (2014)

A Critical Role for FBXW8 and MAPK in Cyclin D1 Degradation and Cancer Cell Proliferation
por: Okabe, Hiroshi, et al.
Publicado: (2006)

FBXW7 Reduces the Cancer Stem Cell-Like Properties of Hepatocellular Carcinoma by Regulating the Ubiquitination and Degradation of ACTL6A
por: Wang, Xing, et al.
Publicado: (2022)

Targeting BET Proteins With a PROTAC Molecule Elicits Potent Anticancer Activity in HCC Cells
por: Zhang, Huapeng, et al.
Publicado: (2020)

Vaccine adjuvant-elicited CD8+ T cell immunity is co-dependent on T-bet and FOXO1
por: Ivanova, Daria L., et al.
Publicado: (2023)

Therapy-induced selective loss of leukemia-initiating activity in murine adult T cell leukemia
por: El Hajj, Hiba, et al.
Publicado: (2010)

Alteration in Expression of miR-32 and FBXW7 Tumor Suppressor in Plasma Samples of Patients with T-cell Acute Lymphoblastic Leukemia
por: Mansouri, Sanaz, et al.
Publicado: (2020)

MYC is a critical target of FBXW7
por: Sato, Mai, et al.
Publicado: (2014)

FBXW2 suppresses migration and invasion of lung cancer cells via promoting β-catenin ubiquitylation and degradation
por: Yang, Fei, et al.
Publicado: (2019)

FBXW4 Is Highly Expressed and Associated With Poor Survival in Acute Myeloid Leukemia
por: Han, Qi, et al.
Publicado: (2020)

Guttiferone K impedes cell cycle re-entry of quiescent prostate cancer cells via stabilization of FBXW7 and subsequent c-MYC degradation
por: Xi, Z, et al.
Publicado: (2016)

FBXW7 promotes autophagy and inhibits proliferation of oral squamous cell carcinoma
por: Qiu, Bo, et al.
Publicado: (2023)

FBXW7 Enhances Cisplatin-Induced Apoptosis in Oral Cancer Cell Lines
por: Yang, Qi, et al.
Publicado: (2022)

FBXW7 loss of function promotes esophageal squamous cell carcinoma progression via elevating MAP4 and ERK phosphorylation
por: Pan, Yunzhi, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_95b0tel5nrvu822dufmej1p5u6